We reviewed intervention studies designed to increase human papillomavirus (HPV)
vaccination coverage to further understand the impact interventions can have on HPV …

Human papillomavirus (HPV) infection is the most common sexually transmitted infection
worldwide. Although most HPV infections are transient and asymptomatic, persistent …

Background Despite the human papillomavirus (HPV) vaccine being a safe, effective cancer
prevention method, its uptake is suboptimal in the United States (US). Previous research has …

Human papillomavirus (HPV) is the most commonly sexually transmitted infection in the
world and the primary cause of cervical cancer. Canada introduced publicly funded HPV …

Objective The objective was to investigate how state level strategies in South Carolina could
maximize HPV vaccine uptake. Design An environmental scan identified barriers, facilitators …

Objectives HPV vaccination rates in the United States lag behind other developed countries.
Educational interventions are primarily directed at patients and parents rather than …

Abstract Background The Human papillomavirus (HPV) vaccine has been available for
protection against HPV-associated cervical cancer and genital warts since 2006 …

OBJECTIVES: To evaluate the effectiveness of a stepped-wedge randomized trial of
Development of Systems and Education for Human Papillomavirus Vaccination (DOSE …

Importance Vaccines against human papillomavirus (HPV) are recommended for routine
use in adolescents aged 11 to 12 years in the United States, but uptake remains suboptimal …

Uptake of human papillomavirus (HPV) vaccine in the United States (US) is far below the
Healthy People 2020 goal of 80% coverage among adolescents. In rural communities, HPV …